Mrv1909 02042018432D 9 8 0 0 0 0 999 V2000 0.0006 -0.0112 0.0000 N 0 3 0 0 0 0 0 0 0 0 0 0 0.4165 -0.6933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6906 -0.4059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4072 0.6747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6866 0.3768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2335 -0.6933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6906 -1.2309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.2335 0.6642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6919 1.2309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 1 4 1 0 0 0 0 1 5 1 0 0 0 0 2 6 1 0 0 0 0 3 7 1 0 0 0 0 4 8 1 0 0 0 0 5 9 1 0 0 0 0 M CHG 1 1 1 M END > DB08837 > drugbank > CC[N+](CC)(CC)CC > InChI=1S/C8H20N/c1-5-9(6-2,7-3)8-4/h5-8H2,1-4H3/q+1 > CBXCPBUEXACCNR-UHFFFAOYSA-N > C8H20N > 130.2511 > 130.159574645 > 0 > 29 > 1.0 > 17.315848567113353 > 1 > 0 > 1 > 0 > tetraethylazanium > -1.24 > -2.5449353321384125 > -4.78 > 0 > 1 > 0 > 1 > 0.0 > 54.8961 > 4 > 1 > 2.77e-03 g/l > 3-(piperazin-1-yl)-1,2-benzothiazole > 1 > DB08837 > experimental; investigational > Tetraethylammonium > Tetraethylammonium bromide; Tetraethylammonium chloride; Tetraethylammonium hydroxide; Tetraethylammonium iodide; Tetraethylammonium phosphate $$$$